外周血表观遗传染色质构象变化可检测甲状腺癌
本研究评估EpiSwitch外周血表观遗传标志物检测甲状腺癌的性能。2014至2016年纳入58例接受甲状腺切除术的甲状腺结节患者,术前采血行EpiSwitch检测并与术后病理比较。结果显示该检测灵敏度89.3%、特异度66.7%,阳性预测值71.4%,阴性预测值87.0%。
要点
- 外周血EpiSwitch表观遗传检测诊断甲状腺癌灵敏度89.3%、特异度66.7%。
- 该检测阳性预测值71.4%,阴性预测值87.0%。
- 研究纳入58例患者,28例(48%)最终病理为甲状腺癌。
核心结论
- 外周血表观遗传检测在甲状腺癌诊断中显示高灵敏度,可作为额外诊断方法。
研究设计与样本
- 2014至2016年招募接受甲状腺切除术的成人甲状腺结节患者,按细针穿刺细胞学分为良性、恶性及意义未明的不典型或滤泡性病变组,术前采集血样,用EpiSwitch检测并与术后病理比较。
- 共纳入58例患者:良性20例、恶性20例、意义未明的不典型或滤泡性病变18例。
主要发现
- 恶性与良性细针穿刺组分析发现6个甲状腺表观遗传标志物。
- 28例(48%)患者最终病理诊断为甲状腺癌。
- 检测正确识别28个恶性结节中的25个,灵敏度89.3%,特异度66.7%。
- 阳性预测值为71.4%,阴性预测值为87.0%。
临床怎么用
- 该外周血表观遗传检测可作为甲状腺癌诊断的辅助方法,高灵敏度有助于减少恶性结节漏诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fine needle aspiration has been the traditional method for diagnosing thyroid cancer. Epigenetic chromatin conformation changes offer an alternative method of diagnosing cancer. The purpose of this study is to evaluate an EpiSwitch assay of epigenetic markers that can be used to diagnose thyroid cancer in blood samples. METHODS: From 2014 to 2016, adult patients with thyroid nodules having thyroidectomy were recruited and grouped based on benign, malignant, and atypia of undetermined significance or follicular lesions of undetermined significance fine needle aspiration cytology. Blood samples were collected before surgery. Final pathologic diagnosis was made from the thyroid specimens. Patients' blood samples were analyzed using the EpiSwitch assay, (Oxford Biodynamics, Oxford, UK), and the results were compared with surgical pathology to determine assay performance. RESULTS: In total, 58 patients were recruited: 20 benign, 20 malignant, and 18 atypia or follicular lesions of undetermined significance. An analysis of the malignant and benign fine needle aspiration groups found 6 epigenetic markers for thyroid. A total of 28 (48%) patients had thyroid cancer. The assay was able to correctly identify 25 of the 28 malignant nodules, showing sensitivity of 89.3% and specificity of 66.7%. The positive predictive value for the assay was 71.4%, whereas the negative predictive value was 87.0%. CONCLUSION: An epigenetic assay of peripheral blood shows high sensitivity in detecting thyroid cancer and provides an additional method for its diagnosis.
引用
- Yan H, Hunter E, Akoulitchev A, et al. Epigenetic chromatin conformation changes in peripheral blood can detect thyroid cancer. Surgery. 2018. PMID: 30377001. doi:10.1016/j.surg.2018.05.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。